Gabelli Funds’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,400
Closed -$10K 1183
2018
Q4
$10K Sell
2,400
-1,300
-35% -$5.42K ﹤0.01% 1132
2018
Q3
$73K Sell
3,700
-3,800
-51% -$75K ﹤0.01% 1128
2018
Q2
$238K Buy
7,500
+1,820
+32% +$57.8K ﹤0.01% 1076
2018
Q1
$210K Sell
5,680
-2,000
-26% -$73.9K ﹤0.01% 1079
2017
Q4
$607K Buy
+7,680
New +$607K ﹤0.01% 973